Clinical Trial Update: Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a topical WR 279,396 for recalcitrant Old World cutaneous leishmaniasis was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• WR 279,396

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: TERMINATED | Results posted: 2019-01-22